Smoking cessation drug to be provided on NHS three years after its withdrawal over carcinogen concerns

NHS England says generic varenicline could help more than 85,000 people stop smoking each year.
Someone smoking cigarette
Pfizer withdrew its varenicline product, Champix, from the market in 2021 owing to concerns over contamination with a probable carcinogen

Shutterstock.com

Smoking cessation drug varenicline will be made available again for NHS patients, three years after it was withdrawn owing to fears over a probable carcinogen, NHS England has announced.

Register for free to keep on reading

Access two premium articles as a registered user.

Register

Already an RPS member or registered? Log in

Register for free to keep on reading

Access two premium articles as a registered user.

Register

Already an RPS member or registered? Log in

Register for free to keep on reading

Access two premium articles as a registered user.

Register

Already an RPS member or registered? Log in

Register for free to keep on reading

Access two premium articles as a registered user.

Register

Already an RPS member or registered? Log in

Last updated